<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Darvon and Darvocet Overdose “Black Box” Warning Required by FDA</title>
	<atom:link href="http://www.aboutlawsuits.com/darvon-and-darvocet-overdose-%e2%80%9cblack-box%e2%80%9d-warning-required-by-fda-4759/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.aboutlawsuits.com/darvon-and-darvocet-overdose-%e2%80%9cblack-box%e2%80%9d-warning-required-by-fda-4759/</link>
	<description>News and Information about Personal Injury Lawsuits</description>
	<lastBuildDate>Thu, 18 Mar 2010 15:05:41 -0500</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: jimmy</title>
		<link>http://www.aboutlawsuits.com/darvon-and-darvocet-overdose-%e2%80%9cblack-box%e2%80%9d-warning-required-by-fda-4759/comment-page-1/#comment-7156</link>
		<dc:creator>jimmy</dc:creator>
		<pubDate>Fri, 17 Jul 2009 05:31:37 +0000</pubDate>
		<guid isPermaLink="false">http://www.aboutlawsuits.com/?p=4759#comment-7156</guid>
		<description>FDA has announced to the makers of pain allaying drugs that have propoxyphene as their component must compulsorily underline the probable risk by overuse on the warning label of such medicines. It has also been said that ailing patients must be made conscious about propoxyphene’s possible hazards, with doctors offering treatment only after evaluation of the patient’s past records and the warning label on the medicine. For more details, refer http://www.zippy-health.com/fda-toughens-stance-on-accentuating-admonition-on-propoxyphene-based-pain-relievers/</description>
		<content:encoded><![CDATA[<p>FDA has announced to the makers of pain allaying drugs that have propoxyphene as their component must compulsorily underline the probable risk by overuse on the warning label of such medicines. It has also been said that ailing patients must be made conscious about propoxyphene’s possible hazards, with doctors offering treatment only after evaluation of the patient’s past records and the warning label on the medicine. For more details, refer <a href="http://www.zippy-health.com/fda-toughens-stance-on-accentuating-admonition-on-propoxyphene-based-pain-relievers/" rel="nofollow">http://www.zippy-health.com/fda-toughens-stance-on-accentuating-admonition-on-propoxyphene-based-pain-relievers/</a></p>
]]></content:encoded>
	</item>
</channel>
</rss>
